About Us
Board of Directors | Back to Overview
-
Harry Garland, Chairman
Dr. Garland has spent his career successfully bringing technological innovations to the marketplace. He holds a doctorate in biophysics from Stanford University, and served on the faculty of Stanford in the School of Engineering. He was co-founder of Cromemco, Inc. and served as president of the company for twelve years. During this time, Cromemco became a leading computer systems company, and a major supplier of computer graphics systems. Following the sale of Cromemco, Dr. Garland joined Canon as Vice President of Canon Research Center America, a position he held for eleven years. He is currently Chairman of Garland Actuarial LLC. He has written three books, and has been awarded 20 U.S. patents.
-
Christian Melander
Dr. Melander focuses on defining small molecules that inhibit and disperse bacterial biofilms. He received his Ph.D. in organic chemistry from Columbia University in 1998, and then worked as a postdoctoral scholar at Caltech under the direction of Professor Peter Dervan from 1998-2001. From 2001-2002, Dr. Melander directed the organic synthesis department at Xencor, Inc. He returned to academic research as a Research Associate at The Scripps Research Institute in the Department of Molecular Biology in the laboratory of Professor Joel Gottesfeld. At Scripps, Dr. Melander utilized pyrrole/imidazole polyamides to treat colon cancer and Friedrich's ataxia. In 2004, Dr. Melander assumed his current position as Assistant Professor of Chemistry at North Carolina State University. Dr. Melander has received numerous awards, including an NIH Chemistry-Biology Research Training Grant and an NIH Postdoctoral Fellowship.
-
John Cavanagh
Dr. Cavanagh is the William Neal Reynolds Distinguished professor of Biochemistry at North Carolina State Unviersity. He is an expert in protein structural biology, particularly in how bacteria are able to protect themselves. Dr. Cavanagh received his Ph.D. in Chemistry/NMR spectroscopy from the University of Cambridge in 1988. He has held positions as a Senior Research Associate at The Scripps Research Institute, Director of Structural Biology at the Wadsworth Center (New York State Department of Health), Associate Professor of Biomedical Sciences (SUNY) and Professor of Chemistry (Purdue). Since 2000 he has been Professor of Biochemistry in the Department of Molecular & Structural Biochemistry at North Carolina State University. Dr. Cavanagh has served on numerous NIH and NSF grant review panels. He is author or co-author of over 90 peer-reviewed research publications and co-author of the well known and successful textbook "Protein NMR Spectroscopy." He has been awarded the Foulerton Gift & Binmore Kenner Fellowship of the Royal Society (1990), The Fullsome Award (1996) and NC State University Alumni Associations Outstanding Research Award (2005).
-
David LaVance
Mr. LaVance is a co-founder and President of Century Capital Associates LLC, and he specializes in financing life science and other emerging technology companies as well as in advising companies about mergers, acquisitions, divestitures and strategic alliances. He is the Chairman of the Board and CEO of Scivanta Medical Corporation (SCVM), a publicly-traded medical device company focused on development of the Hickey Cardiac Monitoring System. He also serves on the Board of Directors for Hologic, Inc. (HOLX), Algynomics, Inc., and Healthy Rebates, Inc. Mr. LaVance has extensive experience in strategic planning for biotechnology and medical device companies, technology licensing and international distribution. Mr. LaVance holds a B.A., cum laude, from Furman University (1976) and a J.D. from the Washington College of Law of the American University (1979).
-
Bill Culpepper
Mr. Culpepper is a proven leader in developing specialty products into best of class, growing, and sustainable businesses. He possesses the entrepreneurial spirit, corporate know-how, and strategic relationships required to successfully develop products. Mr. Culpepper is the Founder, President and CEO of SePRO Corporation, a leading specialty agrichemical company with offices in Carmel, IN and research facilities in Whitakers, NC. Prior to the formation of SePRO Corporation in 1994, he spent more than 25 years with Eli Lilly and DowElanco in a variety of sales, marketing and management roles. Mr. Culpepper is a co-founder and board member of several leading industry organizations, including Responsible Industry for Sound Environment (RISE), the Washington, D.C.-based trade association representing the specialty chemical industry; the RISE Aquatic Working Group; the Aquatic Ecosystem Restoration Foundation and is a board member of Crop Life America, another Washington, D.C.-based trade association representing the agrichemical industry. In addition to industry associations, Mr. Culpepper also serves on various community development boards including the BioCrossroads Advisory Board. BioCrossroads is a privately-funded organization that is dedicated to fully leveraging Indiana's existing world-class life science assets. Mr. Culpepper graduated from NC State in 1966 with a BS in Agronomy. He was a member of the NC State Campaign Steering Committee promoting the Achieve! Campaign, was named CALS Outstanding Alumnus for 2005, and recently completed his term as the first President of the North Carolina Ag Research Foundation.
-
Keith Stoneback
Mr. Stoneback’s diverse career brings a deep and broad base of business development experience to Agile Sciences. Having contributed to the success of several businesses in the start-up phase, as well as a few that required turnaround and/or repositioning; Keith has lead teams to compete and win in the healthcare services, medical device and hospital equipment space during the last 30 years. Throughout his career Mr. Stoneback has demonstrated a keen and intuitive focus on the customer, coupled with a relentless drive to define, validate and then consistently deliver the value proposition. Prior to joining Agile Sciences, Mr. Stoneback planned, organized and then implemented the US market launch of the unique and innovative patient monitoring product developed by Hoana Medical, the Hawaii-based medical device start-up. Prior to that assignment, Mr. Stoneback served as the president of the Health Management Services division of SHPS, an $85M/yr industry leader in providing disease management services to Fortune 1000 employers. Keith was promoted to that position after serving as the Chief Operating Officer for SHPS for several years. Prior to joining SHPS, he served as the CEO and/or president for several healthcare companies, including Surgical Laser Technologies (acquired by Photomedex) and AMSCO, a $300M/yr market leader in hospital decontamination systems. (AMSCO was acquired by Steris). At AMSCO, Keith served as the president of the Scientific Division and was a key member of the management team that took the company public in 1991, providing an 8X return for the private equity investors. Mr. Stoneback began his career with American Hospital Supply Corporation after graduating from Duke University in 1975.